×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Ensuring Patient Engagement Methodologies Are ‘Fit for Purpose’ from the Beginning: A Key Factor for Meaningful Outcomes
Session Chair(s)
Nathalie Bere, MPH
Patient Engagement
European Medicines Agency, Netherlands
Patient data helps ensure more patient-relevant regulatory outcomes. Patients are integrated within EMA and FDA’s regulatory procedures with demonstrated value. Relevant, robust and adaptable methodologies are vital to meet the changing health landscape.
Learning Objective : Discuss patient engagement methodologies within regulatory procedures; Identify value of patient input with tangible evidence; Describe the need for continuous, and adaptable, leveraging of the patient perspective for a better balance between scientific objectives and patient goals and ultimately reach more patient-relevant regulatory outcomes.
Speaker(s)
Panelist
Marco Greco, PhD
European Patients' Forum, Belgium
President
Panelist
Bruno Sepodes, PharmD, PhD, MPH, MSc
INFARMED, Portugal
Vice-Chair CHMP (EMA); Senior Expert INFARMED
Panelist
Andrea Furia-Helms, MPH
FDA, United States
Director of Patient Affairs, Office of Clinical Policy and Programs
Have an account?